Next generation sequencing impacts the classification and management of primary brain tumours

Pathology. 2021 Oct;53(6):780-782. doi: 10.1016/j.pathol.2020.12.008. Epub 2021 Apr 13.

Authors

Veronica K Y Cheung¹, Michael E Buckland², Grace Wei¹, Maggie Lee¹, Joanne Sy³

Affiliations

¹ Department of Neuropathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
² Department of Neuropathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Discipline of Pathology, School of Medical Sciences, Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia.
³ Department of Neuropathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. Electronic address: joanne.sy@health.nsw.gov.au.

PMID: 33858664
DOI: 10.1016/j.pathol.2020.12.008

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Brain Neoplasms / classification*
Brain Neoplasms / genetics
Child
Child, Preschool
Cohort Studies
DNA Copy Number Variations*
Female
Glioma / classification*
Glioma / genetics
High-Throughput Nucleotide Sequencing
Humans
Male
Middle Aged
Molecular Typing
Mutation
Sequence Analysis, DNA
Young Adult